Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Legal Disclaimer: Statements on this site have not been evaluated by the FDA
Baker, L
A 2025 systematic review and meta-analysis in Reviews in Endocrine and Metabolic Disorders found that tirzepatide (the active ingredient in Mounjaro and Zepbound) reduced hsCRP by approximately 33% and IL-6 by approximately 18% compared to placebo across patients with and without diabetes. A growing body of research suggests this effect occurs through direct action on the NF-B pathway, a master switch of inflammation
Schirra et al., 2006)
Circadian Receptor Dynamics and KLOW Metabolism KLOW's metabolic effects depend on beta-adrenergic receptor (-AR) density at adipose tissue, which fluctuates across the circadian cycle in response to cortisol and catecholamine rhythms
US$ 29.69
US$ 25.21
US$ 29.47
US$ 25.74
US$ 24.35
US$ 28.17
